Assay and Drug Development Technologies

Papers
(The H4-Index of Assay and Drug Development Technologies is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
On the Recent Changes to Animal Protection Measures in United States Food and Drug Administration Policy43
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line27
A Perspective on Various Facets of Nanoemulsions and its Commercial Utilities23
Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective18
Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems15
Investigating the Role of Buzhong Yiqi Decoction on Neurogenic Bladder with Network Pharmacology, Molecular Docking, and In Vitro Assays14
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes14
Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells13
Validation of a Novel Supercritical Fluid Extractor/Dryer Combo Instrument13
Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B Antagonists from a High-Throughput Screen12
Liver-Targeting Composite Nanocarrier Delivery System Based on Chitosan Nanoparticles and Phospholipid Complexes12
Spatiotemporal Nanocarriers for Circadian-Aligned Drug Delivery: Advances, Challenges, and Future Directions12
Targeted Drug Delivery with Nanosponges and Nanocrystals: Innovations, Formulation Strategies, and Applications12
Mini Review on the Lyophilization: A Basic Requirement for Formulation Development and Stability Modifier12
0.083166837692261